return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Management Team
Board of Directors
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
27-Dec-2019
Ceasing to be a substantial holder
23-Dec-2019
Change of Director's Interest Notice - GK
23-Dec-2019
Section 708 Certificate
23-Dec-2019
Appendix 3B
20-Dec-2019
DARRT-1 Clinical Data Webinar
17-Dec-2019
Nyrada IPO Offer Fully Subscribed
13-Dec-2019
Unlisted Options Expiring 18 January 2020
9-Dec-2019
Lodgement of Nyrada Inc Supplementary Prospectus
4-Dec-2019
Nyrada Inc Initial Public Offering Opens
3-Dec-2019
Section 708 Certificate - Notes
1
2
3
4
5
6
7
8
9
10
11
Next
